At the Veeva Commercial Summit in Madrid at the end of 2024, pharmaphorum web editor Nicole Raleigh sat down with Pfizer’s ...

Charlotte Allerton, Pfizer's head of medicine design ... "The collaboration allows us to apply our expertise in molecular modelling, AI, and cloud computing towards improving existing ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE ... According to Jim Rossman, head of the Barclays advisory group, there hasn’t been much merger and acquisition activity ...

Riley Wealth Management chief market strategist Art Hogan discusses whether the Fed's interest rate move changed his investment focus on 'The Claman Countdown.' Euro Pacific Capital chief economist ...

Kennedy Jr., a vaccine skeptic, as the head of Health and Human Services ... government scrutiny of drug prices and the growing use of AI for drug discovery whet the M&A appetite of large drugmakers.

There was a sense of guarded optimism in the air at the latest World Economic Forum. But CEOs want their CCOs to step up and ...

There’s a little problem, though: most of the decline in the seven comes down to one company. Apple is down 14 per cent since ...

Technology, banking, and oil companies are the biggest beneficiaries of Trump’s policies, in contrast to renewable energy and ...